Coronary/Structural Heart

Arterys Introduces First Complete AI- and Cloud-powered Solution for Most Challenging Medical Imaging Analysis Workflow

SAN FRANCISCO, Oct. 23, 2018 /PRNewswire/ — Arterys, the leader in intelligent, cloud-based medical imaging software, has introduced more than 80 enhancements to its Cardio AIMR solution, which combines the power of deep learning and cloud computing to automate analysis of cardiac MR images. With these additions, Arterys Cardio AIMR is […]

Neovasc Announces Successful Tiara™ “Live Case” at the 32nd Annual EACTS 2018 Meeting

VANCOUVER, Oct. 22, 2018 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN) (TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced that its Tiara™ (“Tiara”) transcatheter mitral […]

MyoKardia to Host R&D Day on October 30, 2018

SOUTH SAN FRANCISCO, Calif., Oct. 22, 2018 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq: MYOK), a clinical-stage biopharmaceutical company pioneering precision medicine for the treatment of cardiovascular diseases, today announced that it will host a Research and Development (R&D) Day for analysts and investors on Tuesday, October 30, 2018 beginning at […]

Resverlogix Announces Participation at Premier Kidney, Alzheimer’s Disease and Cardiovascular Conferences

CALGARY, Alberta, Oct. 22, 2018 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX: RVX) announced today its participation at premier conferences including the American Society of Nephrology (ASN) Kidney Week 2018, Clinical Trials on Alzheimer’s Disease (CTAD) 2018 and the American Heart Association (AHA) Scientific Sessions 2018. Through […]

Cardiac Dimensions Announces DRG Reimbursement Code for Carillon Mitral Contour System in Germany

KIRKLAND, Wash.–(BUSINESS WIRE)–Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatment modalities to address heart failure and related cardiovascular conditions, today announced that InEK, the German Institute for the Hospital Remuneration System, has granted a permanent DRG (Diagnosis Related Group) code covering reimbursement for the company’s Carillon® Mitral Contour […]

New Study Shows Abbott’s Novel Diagnostic Test has the Potential to Demonstrate Gold Standard Accuracy and Speed, Which Could Help Rule Out Heart Attacks Earlier at the Point of Care

ABBOTT PARK, Ill., Oct. 17, 2018 /PRNewswire/ — For someone experiencing cardiac symptoms in the emergency room, every minute matters as physicians determine whether someone is having a heart attack. New data, published online in JAMA Cardiology, found a new blood test under development that is done right at the patient’s side in as […]

Neovasc Announces Publication of a Peer-Reviewed Article on Tiara™ Cases in Circulation: Cardiovascular Interventions

VANCOUVER, Oct. 16, 2018 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN) (TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced that an original article was published in Circulation: Cardiovascular Interventions titled […]

NobleStitch™ EL Again Expands Global Base With New Center In Ireland

BELFAST, Ireland, Oct. 11, 2018 /PRNewswire/ — NMT2 is excited to announce its expansion of NobleStitch™ EL into the Irish market with first series of PFO closure cases in Belfast, Ireland.  Dr. Mark Spence MD, Interventional Cardiologist and co-founder of the Structural Heart Disease Program at Belfast Health and Social Care Trust in Belfast successfully performed the first procedures […]

Micro Interventional Devices, Inc.™ Successfully Treats First-in-Human Patient with Percutaneous MIA™, Minimally Invasive Annuloplasty Technology

NEWTOWN, Pa., Oct. 12, 2018 /PRNewswire/ — Micro Interventional Devices, Inc.™ (MID) announced today the world’s first percutaneous implantation of its MIA™, Minimally Invasive Annuloplasty, technology for tricuspid and mitral repair.  This marks the first patient enrolled in the transcatheter arm of the STTAR (Study of Transcatheter Tricuspid Annular Repair) trial being conducted in Europe. […]

CHF Solutions Initiates Strategic Collaboration with NI Medical on Management of Fluid Overloaded Patients

EDEN PRAIRIE, Minn., Oct. 11, 2018 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (Nasdaq: CHFS) announced today that it has entered into a collaboration agreement with NI Medical to explore potential clinical synergies between the company’s Aquadex FlexFlow® System and NI Medical’s NICaS Hemodynamic Navigator to assess patient’s fluid volume status and […]